COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray
NCT ID: NCT04878042
Last Updated: 2022-11-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-04-09
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19
NCT04603794
Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
NCT04748783
The Efficacy of Oral Antiseptics Against COVID-19
NCT05214196
Mouth Rinses for Inactivation of COVID-19
NCT04584684
Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva
NCT04723446
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active
Mouth wash and nasal spray containing a diluted solution of hydrogen peroxide
Hydrogen peroxide
Mouth wash and nasal spray 3 times a day for 3 days
Placebo
Mouth wash and nasal spray not containing a diluted solution of hydrogen peroxide
Placebo
Mouth wash and nasal spray 3 times a day for 3 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrogen peroxide
Mouth wash and nasal spray 3 times a day for 3 days
Placebo
Mouth wash and nasal spray 3 times a day for 3 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EPISTATA
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Lazzarino
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio I Lazzarino, MD PhD
Role: PRINCIPAL_INVESTIGATOR
EPISTATA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Nuova ITOR
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20121617
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.